Close

INSM Said FDA Approves Orphan Drug, IPLEX

December 12, 2005 5:16 PM EST Send to a Friend
Insmed Incorporated (NASDAQ: INSM) said the FDA approved IPLEX for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login